These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17337751)

  • 1. No B cells--no active RA? Advances in B cell depletion in RA--repeated therapy under conditions of clinical practice.
    Dörner T; Burmester GR
    Rheumatology (Oxford); 2007 Apr; 46(4):563-4. PubMed ID: 17337751
    [No Abstract]   [Full Text] [Related]  

  • 2. B lymphocyte depletion therapy with rituximab in rheumatoid arthritis.
    Edwards JC; Leandro MJ; Cambridge G
    Rheum Dis Clin North Am; 2004 May; 30(2):393-403, viii. PubMed ID: 15172048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated B-cell depletion in clinical practice.
    Edwards JC; Cambridge G; Leandro MJ
    Rheumatology (Oxford); 2007 Sep; 46(9):1509. PubMed ID: 17623746
    [No Abstract]   [Full Text] [Related]  

  • 4. Reconstitution of B cells after B cell-depletion therapy: Comment on the article by Leandro et al.
    Teng YK; van Tilborg A; van Laar JM
    Arthritis Rheum; 2006 Sep; 54(9):3062-3; author reply 3063. PubMed ID: 16948141
    [No Abstract]   [Full Text] [Related]  

  • 5. Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs.
    Popa C; Leandro MJ; Cambridge G; Edwards JC
    Rheumatology (Oxford); 2007 Apr; 46(4):626-30. PubMed ID: 17189244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term treatment of rheumatoid arthritis with rituximab.
    Caporali R; Caprioli M; Bobbio-Pallavicini F; Bugatti S; Montecucco C
    Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of B lymphocytes in rheumatoid arthritis patients modifies IL-8-anti-IL-8 autoantibody network.
    Keren Z; Braun-Moscovici Y; Markovits D; Rozin A; Nahir M; Balbir-Gurman A; Melamed D
    Clin Immunol; 2009 Oct; 133(1):108-16. PubMed ID: 19632157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
    Guzman Moreno R
    Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate.
    Owczarczyk K; Hellmann M; Fliedner G; Röhrs T; Maizus K; Passon D; Hallek M; Rubbert A
    Ann Rheum Dis; 2008 Nov; 67(11):1648-9. PubMed ID: 18854518
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigms.
    Silverman GJ
    Arthritis Rheum; 2006 Aug; 54(8):2356-67. PubMed ID: 16868991
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune diseases. The B cell slayer.
    Matthews R
    Science; 2007 Nov; 318(5854):1232-3. PubMed ID: 18033858
    [No Abstract]   [Full Text] [Related]  

  • 12. [The humoral response in rheumatoid arthritis and the effect of B-cell depleting therapy].
    Thurlings RM; Vos K; Gerlag DM; Tak PP
    Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1657-61. PubMed ID: 16922350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
    Yukawa N; Mimori T
    Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocyte depletion in rheumatoid arthritis: targeting of CD20.
    Edwards JC; Leandro MJ; Cambridge G
    Curr Dir Autoimmun; 2005; 8():175-92. PubMed ID: 15564721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with B-cell depleting therapy for refractory systemic onset juvenile idiopathic arthritis: a case report.
    Kasher-Meron M; Uziel Y; Amital H
    Rheumatology (Oxford); 2009 Apr; 48(4):445-6. PubMed ID: 19164423
    [No Abstract]   [Full Text] [Related]  

  • 16. B cells, be gone--B-cell depletion in the treatment of rheumatoid arthritis.
    Tsokos GC
    N Engl J Med; 2004 Jun; 350(25):2546-8. PubMed ID: 15201410
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term relief for RA? Potential therapy targets cells that, in rheumatoid arthritis, short circuit and attack the body.
    Health News; 2004 Oct; 10(10):5. PubMed ID: 15584113
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy.
    Leandro MJ; Cooper N; Cambridge G; Ehrenstein MR; Edwards JC
    Rheumatology (Oxford); 2007 Jan; 46(1):29-36. PubMed ID: 16735454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell therapies for rheumatoid arthritis: beyond B cell depletion.
    Calero I; Nieto JA; Sanz I
    Rheum Dis Clin North Am; 2010 May; 36(2):325-43. PubMed ID: 20510237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocrelizumab: a step forward in the evolution of B-cell therapy.
    Kausar F; Mustafa K; Sweis G; Sawaqed R; Alawneh K; Salloum R; Badaracco M; Niewold TB; Sweiss NJ
    Expert Opin Biol Ther; 2009 Jul; 9(7):889-95. PubMed ID: 19463076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.